| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9708 |
| Human Intestinal Absorption | HIA+ | 0.9838 |
| Caco-2 Permeability | Caco2+ | 0.7036 |
| P-glycoprotein Substrate | Non-substrate | 0.8805 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9765 |
| Non-inhibitor | 0.9855 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9107 |
| Distribution |
| Subcellular localization | Lysosome | 0.5810 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8465 |
| CYP450 2D6 Substrate | Non-substrate | 0.8229 |
| CYP450 3A4 Substrate | Non-substrate | 0.8084 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8400 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8999 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9560 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9312 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9791 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8696 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9547 |
| Non-inhibitor | 0.9725 |
| AMES Toxicity | Non AMES toxic | 0.9474 |
| Carcinogens | Carcinogens | 0.6525 |
| Fish Toxicity | Low FHMT | 0.6174 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.6398 |
| Honey Bee Toxicity | High HBT | 0.8081 |
| Biodegradation | Ready biodegradable | 0.6901 |
| Acute Oral Toxicity | III | 0.5860 |
| Carcinogenicity (Three-class) | Non-required | 0.4731 |